The registry is funded by unrestricted grants from four companies: Aimmune, ALK Abello, Allergy Therapeutics and Thermo Fisher.
If you would like to find out more about funding the BRIT Registry please complete the form below.
16 Mar 2023
Latest news,
15 Mar 2023